Richard Horowitz
Internal Medicine · Hyde Park, NYNPI 1457417388
Payments from drug & device makers
Across 161 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- 60 Degrees Pharmaceuticals$986
- CSL Behring$650
- Takeda Pharmaceuticals U.S.A., Inc.$525
- Lilly USA, LLC$342
- AbbVie$228
- Lundbeck LLC$217
- plus $1K from 17 others
What the payments were for
- Consulting fees$90023%
- Food & beverage$3,07177%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| 60 Degrees Pharmaceuticals | 2 | $986 |
| CSL Behring | 31 | $650 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $525 |
| Lilly USA, LLC | 18 | $342 |
| AbbVie | 10 | $228 |
| Lundbeck LLC | 13 | $217 |
| Pfizer | 9 | $172 |
| Teva Pharmaceuticals USA, Inc. | 9 | $130 |
| Arbor Pharmaceuticals, Inc. | 9 | $129 |
| Amgen | 5 | $90 |
| Shire North American Group Inc | 5 | $85 |
| Grifols USA, LLC | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $58 |
| Prugen, Inc. Pharmaceuticals | 3 | $47 |
| Vyera Pharmaceuticals, LLC | 3 | $36 |
| Octapharma USA, Inc. | 2 | $33 |
| Romark Laboratories, LC | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| Argenx US, Inc. | 1 | $20 |
| Bio Products Laboratory USA, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARAKODA$900
How this compares
$3,971 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Leucovorin Calcium | 39 | $13,485 |
| Doxepin Hcl | 11 | $3,436 |
| Nystatin | 30 | $2,200 |
| Liothyronine Sodium | 29 | $1,818 |
| Rifampin | 31 | $1,557 |
| Famciclovir | 31 | $1,543 |
| Dapsone | 22 | $1,176 |
| Azithromycin | 18 | $727 |
| Midodrine Hcl | 11 | $638 |
| Minocycline Hcl | 22 | $617 |
| Memantine Hcl | 12 | $564 |
| Famotidine | 18 | $534 |
| Levothyroxine Sodium | 29 | $435 |
| Gabapentin | 16 | $431 |
| Montelukast Sodium | 17 | $400 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hyde Park
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.